Dyslipidaemia [dsyn]
Cardiovascular disease [dsyn]
Women [popg]
Cardiovascular disease [dsyn]
Major [qlco]
Death [orgf]
Women [popg]
Developed Countries [qlco]
Dyslipidaemia [dsyn]
Highly [qlco]
Prevalence [qnco]
Women [popg]
Menopause [phsf]
Elevated [qlco]
Low Density Lipoprotein Cholesterol [bacs, strd]
Identified [qlco]
Lipid [lipd]
Parameter [spco]
Gender [orga]
Cholesterol, HDL [bacs, lipd]
Triglycerides [bacs, lipd]
More [ftcn]
Associated [qlco]
studies [lbpr]
CARDIOVASCULAR [bdsy]
Risk [qlco]
Women [popg]
Menopause [phsf]
Show [inpr]
To [qlco]
Associated [qlco]
Increase [ftcn]
Cholesterol, LDL [bacs, strd]
Decrease [qlco]
Cholesterol, HDL [bacs, lipd]
effects [qlco]
Lipid [lipd]
Profile [lbpr]
Hormone replacement therapy [topp]
Not [ftcn]
Recommended [idcn]
Primary [qlco]
Secondary Prevention [topp]
Cardiovascular disease [dsyn]
Women [popg]
Late [tmco]
Meta-Analysis [inpr]
Statin [orch, phsu]
Trial [resa]
Gender [orga]
Specific [qlco]
Outcome [ftcn]
Show [inpr]
Similar [qlco]
Benefit [qnco]
Women [popg]
Men [popg]
Addition [ftcn]
ezetimibe [orch, phsu]
Simvastatin [orch, phsu]
Patients [podg]
Syndromes, Acute Coronary [dsyn]
Show [inpr]
Further [spco]
reduction [npop]
Primary Endpoint [irda]
Gender [orga]
gender differences [orga]
Drug [phsu]
treatment [ftcn]
Dyslipidaemia [dsyn]
Current [tmco]
Guidelines [inpr]
To [qlco]
Over [spco]
treatment [ftcn]
Suggest [idcn]
Risk [qlco]
estimation [menp]
Initiate [idcn]
Lipid [lipd]
lowering [spco]
treatment [ftcn]
Women [popg]
Manifest [ftcn]
Cardiovascular disease [dsyn]
